MedPath

Randomized controlled trial of peritoneovenous shunting in patients with refractory ascites (JIVROSG-0803)

Phase 3
Conditions
Malignant refractory ascites
Registration Number
JPRN-UMIN000003469
Lead Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1. Non-malignant ascites 2. Previous peritoneovenous shunt 3. More than four weeks after the occurrence of refractory ascites 4. Bloody, mucinous or infectious ascites 5. Malignant peritoneal methothelioma 6. Ascites caused by liver cirrhosis 7. Clinically significant cardiac failure, renal failure, or bleeding tendency 8. Difficulties in the evaluation of quality-of-life 9. Pregnancy 10. Contraindication decided by attending physician

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of the symptoms from ascites.
Secondary Outcome Measures
NameTimeMethod
Improvement of health-related QOL/ toxicity profile/ survival time.
© Copyright 2025. All Rights Reserved by MedPath